stocksCORONA
CORONA

CORONA Remedies Ltd.

2,051.10+9.1 (+0.45%)
23 Oct, 12:00 AM

Annual Reports and Financial Documents

CORONA Remedies Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.
20252026
Annual Reports—FY 2026
Quarterly Results
Conference Calls—
Presentations—

Corporate Announcements and Regulatory Filings

CORONA Remedies Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.
  1. Press Release / Media Release22 Oct 2026
    Announcement under Regulation 30 (LODR)-Press Release / Media Release
    Press Release on GMP Compliance Certification from Brazilian Health Regulatory Agency, ANVISA, Brazil
  2. General22 Oct 2026
    Intimation Regarding Receipt Of GMP Compliance Certification From Brazilian Health Regulatory Agency, ANVISA, Brazil
    Intimation regarding receipt of GMP Compliance Certification from Brazilian Health Regulatory Agency, ANVISA, Brazil for OSD manufacturing facility and Hormone manufacturing facility of ....
  3. Analyst / Investor Meet16 Oct 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Intimation for Schedule of Analyst / Investor Conference
  4. Board Meeting16 Oct 2026
    Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results On Standalone And Consolidated Basis For The Second Quarter And Half Year Ended On September 30, 2026
    Corona Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/10/2026 ,inter alia, to consider and approve Unaudited Financial Results ....
  5. Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 20185 Oct 2026
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
    Certificate pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026
  6. Credit Rating30 Sept 2026
    Announcement under Regulation 30 (LODR)-Credit Rating
    Credit Rating
  7. Closure of Trading Window28 Sept 2026
    Closure of Trading Window
    Intimation of Closure of Trading Window
  8. Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 201119 Sept 2026
    Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
    The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sepia Investments Ltd, Sage Investment Trust ....
  9. Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 201119 Sept 2026
    Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
    The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sepia Investments Ltd, Sage Investment Trust ....
  10. Analyst / Investor Meet18 Sept 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Intimation of participation in Analyst / Investor meet
  11. General10 Sept 2026
    Clarification On Movement In Volume
    Reply to Clarification
  12. Analyst / Investor Meet20 Aug 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Intimation of participation in Analyst / Investor Conference
  13. Analyst / Investor Meet10 Aug 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Intimation for Schedule of Analysts / Investor Conference
  14. Analyst / Investor Meet3 Aug 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
    Audio Recording of Q1 FY27 Earnings Conference Call with Analysts / Investors
  15. Newspaper Publication1 Aug 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Newspaper Publication of Unaudited Financial Results for the first quarter and three months ended June 30, 2026
  16. Press Release / Media Release31 Jul 2026
    Announcement under Regulation 30 (LODR)-Press Release / Media Release
    Press Release on Financial Results for Q1FY27
  17. Outcome of Board Meeting31 Jul 2026
    Board Meeting Outcome for Outcome Of Board Meeting
    Outcome of Board Meeting
  18. Analyst / Investor Meet22 Jul 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Intimation for Schedule of Analysts / Investor Conference
  19. Board Meeting17 Jul 2026
    Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results On Standalone And Consolidated Basis For First Quarter And Three Months Ended June 30, 2026
    Corona Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/07/2026 ,inter alia, to consider and approve Unaudited Financial Results ....
  20. AGM10 Jul 2026
    Shareholders Meeting / Postal Ballot- Scrutinizer''s Report
    Declaration of Voting Results and Scrutinizer''s Report for 22nd Annual General Meeting

Frequently Asked Questions

Where can I download the annual report of CORONA Remedies Ltd.?
Annual reports of CORONA Remedies Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.
Where can I find the quarterly results of CORONA Remedies Ltd.?
Quarterly earnings results and presentations of CORONA Remedies Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.
Does CORONA Remedies Ltd. publish earnings call transcripts?
Earnings call transcripts of CORONA Remedies Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.
Where can I find investor presentations of CORONA Remedies Ltd.?
Investor presentations and annual day presentations of CORONA Remedies Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.
What are the recent corporate announcements of CORONA Remedies Ltd.?
Corporate announcements and regulatory filings of CORONA Remedies Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.
How do I access the regulatory filings of CORONA Remedies Ltd.?
Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of CORONA Remedies Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.
What is the ISIN of CORONA Remedies Ltd.?
The ISIN (International Securities Identification Number) of CORONA Remedies Ltd. is INE02ZQ01018. This is the unique identifier used across exchanges and depositories.
On which stock exchange is CORONA Remedies Ltd. listed?
CORONA Remedies Ltd. is listed on NSE and BSE. The NSE symbol is CORONA and the BSE code is -.
Where can I find the shareholding pattern of CORONA Remedies Ltd.?
The quarterly shareholding pattern of CORONA Remedies Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.
How current is the data for CORONA Remedies Ltd. on Sharpely?
Share price data for CORONA Remedies Ltd. is updated as of 23 Oct 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.